Why the study?
Does the Trifecta aortic pericardial valve provide safe and effective midterm hemodynamic performance and clinical outcomes in patients requiring aortic valve replacement?
Population
710 patients undergoing surgical implantation of a pericardial stented aortic prosthesis, mean age 72.4 ±…
Design
Cohort
Follow-up
6 years
Authors
Loading...
Supports Trifecta use in aortic replacement; leaves open need for randomized comparisons to other bioprostheses.
Does the Trifecta aortic pericardial valve provide safe and effective midterm hemodynamic performance and clinical outcomes in patients requiring aortic valve replacement?
The Trifecta aortic pericardial valve demonstrates excellent midterm durability, safety, and hemodynamic performance at 6-year follow-up.
Goldman et al. (2016) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: